People: Biogen Inc (BIIB.O)

BIIB.O on Nasdaq

396.21USD
29 Jun 2015
Change (% chg)

$-12.52 (-3.06%)
Prev Close
$408.73
Open
$404.50
Day's High
$407.86
Day's Low
$395.90
Volume
1,474,127
Avg. Vol
1,608,037
52-wk High
$480.18
52-wk Low
$290.85

Search Stocks

Holtzman, Steven 

Mr. Steven H. Holtzman is Executive Vice President - Corporate Development of Biogen Idec Inc., since January 2011. Prior to that, Mr. Holtzman was a founder of Infinity Pharmaceuticals, Inc., a drug discovery and development company, where he served as Chair of the Board of Directors from company inception in 2001 to November 2012, Executive Chair of the Board of Directors in 2010 and as Chief Executive Officer from 2001 to December 2009. From 1994 to 2001, Mr. Holtzman was Chief Business Officer at Millennium Pharmaceuticals Inc., a biopharmaceutical company. From 1986 to 1994, he was a founder, member of the Board of Directors and Executive Vice President of DNX Corporation, a biotechnology company. From 1996 to 2001, Mr. Holtzman served as presidential appointee to the national Bioethics Advisory Commission. Mr. Holtzman received his B.A. from Michigan State University and B.Phil. graduate degree from Oxford University which he attended as a Rhodes Scholar.

Basic Compensation

Total Annual Compensation, USD 1,318,960
Restricted Stock Awards, USD 1,988,880
Long-Term Incentive Plans, USD --
All Other, USD 35,780
Fiscal Year Total, USD 3,343,620

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Stelios Papadopoulos

--

George Scangos

18,631,400

Paul Clancy

4,690,020

Kenneth Di Pietro

3,254,520

Susan Alexander

2,162,200

John Cox

3,671,600
As Of  30 Dec 2014
Search Stocks